Literature DB >> 11739622

Cytosolic O-glycosylation is abundant in nerve terminals.

R N Cole1, G W Hart.   

Abstract

Phosphorylation plays a key role in regulating growth cone migration and protein trafficking in nerve terminals. Here we show that nerve terminal proteins contain another abundant post-translational modification: beta-N-acetylglucosamine linked to hydroxyls of serines or threonines (O-GlcNAc(1)). O-GlcNAc modifications are essential for embryogenesis and mounting evidence suggests that O-GlcNAc is a regulatory modification that affects many phosphorylated proteins. We show that the activity and expression of O-GlcNAc transferase (OGT) and N-acetyl-beta-D-glucosaminidase (O-GlcNAcase), the two enzymes regulating O-GlcNAc modifications, are present in nerve terminal structures (synaptosomes) and are particularily abundant in the cytosol of synaptosomes. Numerous synaptosome proteins are highly modified with O-GlcNAc. Although most of these proteins are present in low abundance, we identified by proteomic analysis three neuron-specific O-GlcNAc modified proteins: collapsin response mediator protein-2 (CRMP-2), ubiquitin carboxyl hydrolase-L1 (UCH-L1) and beta-synuclein. CRMP-2, which is involved in growth cone collapse, is a major O-GlcNAc modified protein in synaptosomes. All three proteins are implicated in regulatory cascades that mediate intracellular signaling or neurodegenerative diseases. We propose that O-GlcNAc modifications in the nerve terminal help regulate the functions of these and other synaptosome proteins, and that O-GlcNAc may play a role in neurodegenerative disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739622     DOI: 10.1046/j.1471-4159.2001.00655.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  72 in total

Review 1.  Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications.

Authors:  Kenneth Hensley; Kalina Venkova; Alexandar Christov; William Gunning; Joshua Park
Journal:  Mol Neurobiol       Date:  2011-01-28       Impact factor: 5.590

2.  Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain.

Authors:  Nelly Khidekel; Scott B Ficarro; Eric C Peters; Linda C Hsieh-Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

3.  Global identification and characterization of both O-GlcNAcylation and phosphorylation at the murine synapse.

Authors:  Jonathan C Trinidad; David T Barkan; Brittany F Gulledge; Agnes Thalhammer; Andrej Sali; Ralf Schoepfer; Alma L Burlingame
Journal:  Mol Cell Proteomics       Date:  2012-05-29       Impact factor: 5.911

4.  O-GlcNAc transferase regulates excitatory synapse maturity.

Authors:  Olof Lagerlöf; Gerald W Hart; Richard L Huganir
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-31       Impact factor: 11.205

Review 5.  Synaptosome proteomics.

Authors:  Fengju Bai; Frank A Witzmann
Journal:  Subcell Biochem       Date:  2007

Review 6.  Chemical approaches to understanding O-GlcNAc glycosylation in the brain.

Authors:  Jessica E Rexach; Peter M Clark; Linda C Hsieh-Wilson
Journal:  Nat Chem Biol       Date:  2008-02       Impact factor: 15.040

7.  Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease.

Authors:  Zhihua Liu; Robin K Meray; Tom N Grammatopoulos; Ross A Fredenburg; Mark R Cookson; Yichin Liu; Todd Logan; Peter T Lansbury
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-04       Impact factor: 11.205

8.  O-linked β-N-acetylglucosamine (O-GlcNAc) site thr-87 regulates synapsin I localization to synapses and size of the reserve pool of synaptic vesicles.

Authors:  Yuliya Skorobogatko; Ashly Landicho; Robert J Chalkley; Andrew V Kossenkov; Gianluca Gallo; Keith Vosseller
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

Review 9.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

Review 10.  Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma.

Authors:  Hussein Abou-Abbass; Hadi Abou-El-Hassan; Hisham Bahmad; Kazem Zibara; Abir Zebian; Rabab Youssef; Joy Ismail; Rui Zhu; Shiyue Zhou; Xue Dong; Mayse Nasser; Marwan Bahmad; Hala Darwish; Yehia Mechref; Firas Kobeissy
Journal:  Electrophoresis       Date:  2016-04-04       Impact factor: 3.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.